microRNA Biomarkers as Potential Diagnostic Markers for Cancer - Genomic Biomarkers for Pharmaceutical Development - page 119

[108] Habbe N, Koorstra JB, Mendell JT, Offerhaus GJ, Ryu JK, Feldmann G, et al. MicroRNA miR-155 is a bio-
marker of early pancreatic neoplasia. Cancer Biol Ther 2009;8:340-6.
[109] Ryu JK, Matthaei H, Dal Molin M, Hong SM, Canto MI, Schulick RD, et al. Elevated microRNA miR-21
levels in pancreatic cyst luid are predictive of mucinous precursor lesions of ductal adenocarcinoma.
Pancreatology 2011;11:343-50.
[110] Matthaei H, Wylie D, Lloyd MB, Dal Molin M, Kemppainen J, Mayo SC, et al. miRNA biomarkers in cyst
luid augment the diagnosis and management of pancreatic cysts. Clin Cancer Res 2012;18:4713-24.
[111] Giovannetti E, Funel N, Peters GJ, Del Chiaro M, Erozenci LA, Vasile E, et al. MicroRNA-21 in pancreatic
cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of
gemcitabine activity. Cancer Res 2010;70:4528-38.
[112] Tavano F, di Mola FF, Piepoli A, Panza A, Copetti M, Burbaci FP, et al. Changes in miR-143 and miR-21
expression and clinicopathological correlations in pancreatic cancers. Pancreas 2012;41:1280-4.
[113] Kong X, Du Y, Wang G, Gao J, Gong Y, Li L, et al. Detection of differentially expressed microRNAs in serum
of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis. Dig
Dis Sci 2011;56:602-9.
[114] Preis M, Gardner TB, Gordon SR, Pipas JM, Mackenzie TA, Klein EE, et al. MicroRNA-10b expression cor-
relates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma. Clin Cancer
Res 2011;17:5812-21.
[115] Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: global burden
of disease study. Lancet 1997;349:1498-504.
[116] Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, et al. Detection of elevated levels of
tumor-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol
2008;141:672-5.
[117] Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating micro-
RNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008;105:10513-18.
[118] Brase JC, Wuttig D, Kuner R, Sultmann H. Serum microRNAs as non-invasive biomarkers for cancer. Mol
Cancer 2010;9:306.
[119] Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, et al. Detection of microRNA expression in human
peripheral blood microvesicles. PLoS One 2008;3:e3694.
[120] Michael A, Bajracharya SD, Yuen PS, Zhou H, Star RA, Illei GG, et al. Exosomes from human saliva as a
source of microRNA biomarkers. Oral Dis 2010;16:34-8.
[121] Dimov I, Jankovic Velickovic L, Stefanovic V. Urinary exosomes. ScientiicWorldJournal 2009;9:1107-18.
[122] Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, et al. Glioblastoma microvesicles
transport RNA and proteins that promote tumor growth and provide diagnostic biomarkers. Nat Cell Biol
2008;10:1470-6.
[123] Weickmann JL, Glitz DG. Human ribonucleases. Quantitation of pancreatic-like enzymes in serum, urine,
and organ preparations. J Biol Chem 1982;257:8705-10.
[124] Gibbings DJ, Ciaudo C, Erhardt M, Voinnet O. Multivesicular bodies associate with components of miRNA
effector complexes and modulate miRNA activity. Nat Cell Biol 2009;11:1143-9.
[125] Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007;9:654-9.
[126] Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, van Eijndhoven MA, Hopmans ES, Lindenberg JL, et al.
Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci USA 2010;107:6328-33.
[127] Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, et al. A MicroRNA signature associated
with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005;353:1793-801.
[128] Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation
of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA
2002;99:15524-9.
[129] Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, Dumitru CD, et al. MicroRNA proiling reveals distinct
signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 2004;101:11755-60.
[130] Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, Efanov A, Maximov V, et al. TCL1 expression in
chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 2006;66:11590-3.
[131] Tanaka M, Oikawa K, Takanashi M, Kudo M, Ohyashiki J, Ohyashiki K, et al. Down-regulation of miR-92 in
human plasma is a novel marker for acute leukemia patients. PLoS One 2009;4:e5532.